InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: oneragman post# 379474

Tuesday, 06/07/2022 3:46:17 PM

Tuesday, June 07, 2022 3:46:17 PM

Post# of 425648
o-

AG ...

(i) it will get "automatically" generic tier ... less co-pay
(ii) 100% is the same as V ... same COGS, process, etc. the only difference that it is w/o name (Vascepa) ... but could be branded (e.g. Vazkepa)
(iii) meanwhile it will take market share from V it does not matter ... does not decrease overall revenue ... MEANWHILE will take market share from gV ... overall market share will be higher

Best,
G

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Notice: This post is not investment advice, and not a recommendation to neither buy nor hold nor sell.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News